- List
- By Topic
- On Map
- Search Details

pharmacogenomics
Need help? See RSS Feeds
Choose a feed type:

pharmacogenomics (511 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03730870 | Not yet recruiting | Pharmacogenomics for Improving Pediatric ADHD Treatment |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
210 | All | 6 Years to 18 Years (Child, Adult) | NCT03730870 | 2018-01 | February 2019 | December 2019 | February 2020 | November 5, 2018 | January 30, 2019 |
|
|||
2 | NCT03257605 | Completed | A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly |
|
Observational |
|
Industry / Other |
|
|
296 | All | 55 Years and older (Adult, Older Adult) | NCT03257605 | PHARM-GENOME-PACE 1173 | PACE | May 2014 | June 2016 | August 2017 | August 22, 2017 | August 22, 2017 | |||||
3 | NCT01611545 | Completed | Pharmacogenomics and Effective Treatment With Clopidogrel |
|
|
Observational |
|
Other |
|
130 | All | 18 Years and older (Adult, Older Adult) | NCT01611545 | AIHG-1410-Clopidogrel | June 2012 | January 2015 | January 2015 | June 5, 2012 | June 11, 2015 |
|
|||||
4 | NCT03322189 | Enrolling by invitation | Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s) |
|
|
Observational |
|
Other |
|
|
200 | All | 18 Years to 64 Years (Adult) | NCT03322189 | PAS1463 | March 22, 2017 | March 22, 2020 | April 1, 2020 | October 26, 2017 | January 23, 2019 |
|
||||
5 | NCT03093818 | Recruiting | PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
8100 | All | 18 Years and older (Adult, Older Adult) | NCT03093818 | 668353 (U-PGx) | PREPARE | March 20, 2017 | December 2019 | December 2019 | March 28, 2017 | October 2, 2018 |
|
||
6 | NCT03228953 | Recruiting | Pharmacogenomic Testing in Major Depressive Disorder |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
206 | All | 21 Years to 80 Years (Adult, Older Adult) | NCT03228953 | AAAR4283 | August 2017 | May 15, 2021 | May 15, 2021 | July 25, 2017 | August 4, 2017 |
|
|||
7 | NCT01495845 | Completed | Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy |
|
|
Interventional |
Phase 1 |
|
Other / Industry |
|
|
48 | All | 18 Years and older (Adult, Older Adult) | NCT01495845 | 10-1558 | December 2011 | June 2012 | June 2012 | December 20, 2011 | June 8, 2012 |
|
|||
8 | NCT02542397 | Recruiting | LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
78 | All | 18 Years and older (Adult, Older Adult) | NCT02542397 | LCI-NOS-PAIN-001 | September 2015 | February 2019 | February 2019 | September 7, 2015 | November 21, 2018 |
|
|||
9 | NCT03225820 | Recruiting | Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities |
|
Observational |
|
Other / NIH |
|
|
1000 | All | 18 Years and older (Adult, Older Adult) | NCT03225820 | IRB17-0890 U54MD010723 |
November 9, 2017 | September 2020 | September 2020 | July 21, 2017 | April 18, 2018 |
|
|||||
10 | NCT02374840 | Unknown † | Pharmacogenomics Registry to Assess Clinical Utility |
|
Observational |
|
Industry |
|
|
340778 | All | 2 Years and older (Child, Adult, Older Adult) | NCT02374840 | CD-2014-102 | PREACT | February 2019 | March 2, 2015 | July 22, 2015 | |||||||
11 | NCT03145272 | Recruiting | Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
20 | All | 1 Year to 6 Years (Child) | NCT03145272 | SI407/2016 | PedPK | October 8, 2018 | March 1, 2019 | April 1, 2019 | May 9, 2017 | February 15, 2019 |
|
||
12 | NCT02081872 | Unknown † | Utility of PharmacoGenomics for Reducing Adverse Drug Effects |
|
Observational |
|
Industry |
|
|
279000 | All | 18 Years and older (Adult, Older Adult) | NCT02081872 | 2013-101 | UPGRADE | April 2014 | July 2017 | July 2017 | March 7, 2014 | October 8, 2015 |
|
||||
13 | NCT03591224 | Recruiting | Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy |
|
|
Interventional |
Not Applicable |
|
Industry / Other |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT03591224 | Pro00025062 | April 17, 2018 | April 17, 2019 | April 17, 2019 | July 19, 2018 | July 19, 2018 |
|
|||
14 | NCT02453997 | Recruiting | Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis |
|
Observational |
|
Other |
|
|
150 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02453997 | UW12-462 | October 2012 | October 2017 | December 2019 | May 27, 2015 | June 22, 2017 |
|
|||||
15 | NCT02932579 | Recruiting | Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
238 | All | 18 Years to 35 Years (Adult) | NCT02932579 | UofREDC RSRB00058833 |
July 1, 2017 | November 30, 2019 | November 30, 2020 | October 13, 2016 | February 15, 2019 |
|
|||
16 | NCT02670564 | Recruiting | ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
1000 | All | up to 18 Years (Child, Adult) | NCT02670564 | ZH 2014-0535 NZ 2015-069 GE 15-034 |
April 2013 | April 2018 | April 2023 | February 2, 2016 | February 28, 2017 |
|
|||
17 | NCT03749629 | Not yet recruiting | Comparative Effectiveness of Pharmacogenomics for Treatment of Depression |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
400 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03749629 | 2018P002499 | CEPIO-D | February 1, 2019 | February 1, 2020 | February 1, 2020 | November 21, 2018 | November 21, 2018 | |||
18 | NCT03352622 | Recruiting | Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
372 | All | 18 Years and older (Adult, Older Adult) | NCT03352622 | Pharmacogenomic | October 17, 2017 | October 17, 2018 | September 17, 2020 | November 24, 2017 | February 21, 2018 |
|
|||
19 | NCT03270891 | Recruiting | Pharmacogenomic Testing in Primary Care |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
122 | All | 18 Years and older (Adult, Older Adult) | NCT03270891 | HUM00121185 | December 1, 2017 | December 2019 | December 2019 | September 1, 2017 | June 12, 2018 |
|
|||
20 | NCT03249285 | Recruiting | Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
300 | All | 25 Years to 60 Years (Adult) | NCT03249285 | udraCT NUMBER: 2015-001888-39 | PGX-HT | March 2016 | March 2018 | November 2018 | August 15, 2017 | August 15, 2017 |
|
||
21 | NCT03161002 | Recruiting | A Research in Pharmacogenomics and Accurate Medication of New Antiplatelet Drug Ticagrelor |
|
|
Observational |
|
Other |
|
|
400 | All | 18 Years and older (Adult, Older Adult) | NCT03161002 | 2016[1235] | May 31, 2017 | September 2019 | December 2019 | May 19, 2017 | November 14, 2018 |
|
||||
22 | NCT03161496 | Recruiting | A Research in Pharmacogenomics and Accurate Medication of Novel Oral Anticoagulants |
|
|
Observational |
|
Other |
|
|
1200 | All | 18 Years and older (Adult, Older Adult) | NCT03161496 | 2016[1236] | June 6, 2017 | September 2019 | December 2019 | May 19, 2017 | November 14, 2018 |
|
||||
23 | NCT01610063 | Completed Has Results |
Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
227 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01610063 | 08-005610 | January 2009 | November 2011 | May 2013 | June 1, 2012 | March 30, 2017 | March 30, 2017 |
|
||
24 | NCT03261908 | Recruiting | A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction |
|
|
Observational |
|
Other |
|
|
2200 | All | 18 Years and older (Adult, Older Adult) | NCT03261908 | 2016[1237] | August 2018 | December 2018 | December 2018 | August 25, 2017 | May 22, 2018 |
|
||||
25 | NCT01097343 | Completed Has Results |
Clopidogrel Pharmacogenomics Project |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT01097343 | 09-2104 | March 2010 | April 2011 | May 2011 | April 1, 2010 | December 12, 2017 | March 26, 2014 |
|
||
26 | NCT03579121 | Recruiting | Genomic Opioid Optimization of Dosing and Selections (GOODS) Study |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
80 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03579121 | 17-006577 | October 12, 2018 | April 2019 | May 2019 | July 6, 2018 | November 6, 2018 |
|
|||
27 | NCT02855580 | Completed | Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic |
|
Observational |
|
Other |
|
|
71 | All | 8 Years to 20 Years (Child, Adult) | NCT02855580 | IRB201601035 | PGX | September 2016 | July 6, 2017 | July 6, 2017 | August 4, 2016 | August 1, 2018 |
|
||||
28 | NCT02095769 | Unknown † | Pharmacogenomic Testing Of the Elderly To Reduce Morbidity |
|
Observational |
|
Industry / Other |
|
|
280000 | All | 18 Years and older (Adult, Older Adult) | NCT02095769 | 201301 | POETRY | April 2014 | January 2017 | January 2017 | March 26, 2014 | February 24, 2015 |
|
||||
29 | NCT03259399 | Recruiting | A Pharmacogenomics Study of Safety and Efficacy of Enalapril or Enalapril-Folic Acid Therapy in Hypertensive Patients. |
|
|
Observational |
|
Other |
|
|
2200 | All | 18 Years and older (Adult, Older Adult) | NCT03259399 | 2016[1238] | August 16, 2017 | April 2019 | April 2019 | August 23, 2017 | January 1, 2019 |
|
||||
30 | NCT01452152 | Terminated Has Results |
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study |
|
|
Interventional |
Phase 4 |
|
Other / NIH |
|
|
9 | All | 20 Years to 74 Years (Adult, Older Adult) | NCT01452152 | HP-00047385 9U01HL105198-06 |
PAPI-2 | February 2012 | July 2013 | July 2013 | October 14, 2011 | March 5, 2018 | June 28, 2016 |
|
|
31 | NCT01272531 | Unknown † | Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD) |
|
|
Observational |
|
Other |
|
|
880 | All | 18 Years and older (Adult, Older Adult) | NCT01272531 | NIH 1 U01 MH92758-01 | January 2011 | January 2013 | January 2016 | January 7, 2011 | April 10, 2012 |
|
||||
32 | NCT01228357 | Unknown † | Predict Antidepressant Responsiveness Using Pharmacogenomics |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
1000 | All | 19 Years to 89 Years (Adult, Older Adult) | NCT01228357 | 2003-08-07 | February 2003 | December 2018 | December 2018 | October 26, 2010 | December 31, 2015 |
|
|||
33 | NCT01138267 | Completed | Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV) |
|
Observational |
|
Other |
|
|
450 | All | 18 Years and older (Adult, Older Adult) | NCT01138267 | HIV-NAT103 | May 2009 | December 2010 | December 2010 | June 7, 2010 | February 7, 2011 |
|
|||||
34 | NCT03006991 | Recruiting | Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics |
|
|
Observational |
|
Other |
|
|
100 | All | 1 Month to 18 Years (Child, Adult) | NCT03006991 | 81603203 | November 2016 | December 2020 | December 2023 | December 30, 2016 | December 30, 2016 |
|
||||
35 | NCT03092037 | Recruiting | Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics |
|
|
Observational |
|
Other |
|
|
700 | Female | 18 Years to 45 Years (Adult) | NCT03092037 | 16-2462 | March 23, 2017 | March 2021 | October 2021 | March 27, 2017 | February 15, 2019 |
|
||||
36 | NCT03150004 | Recruiting | Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
90 | All | 18 Years and older (Adult, Older Adult) | NCT03150004 | PRO29327 | June 14, 2017 | January 1, 2019 | June 1, 2020 | May 11, 2017 | July 3, 2018 |
|
|||
37 | NCT02625155 | Recruiting | Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens |
|
|
Interventional |
Phase 4 |
|
Industry / Other |
|
|
14000 | All | 12 Years and older (Child, Adult, Older Adult) | NCT02625155 | 2017-001 | SPHERE | December 2015 | December 2018 | December 9, 2015 | February 28, 2018 |
|
|||
38 | NCT02711592 | Recruiting | Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
12 | All | 18 Years and older (Adult, Older Adult) | NCT02711592 | 15-037 | March 2016 | March 2019 | March 2019 | March 17, 2016 | October 18, 2018 |
|
|||
39 | NCT01274065 | Completed | Developing an Interdisciplinary Pharmacogenomic Treatment Approach to Reduce Medication Burden and Improve Outcomes |
|
|
Observational |
|
Other |
|
38 | All | 13 Years and older (Child, Adult, Older Adult) | NCT01274065 | ARI-1290-Pharm | September 2009 | November 2014 | November 2014 | January 11, 2011 | January 14, 2015 | ||||||
40 | NCT00321217 | Unknown † | Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis |
|
Observational |
|
Other |
|
700 | All | 18 Years and older (Adult, Older Adult) | NCT00321217 | pharmacogenomics of anti-TNF | May 2004 | November 2013 | April 2014 | May 3, 2006 | August 16, 2012 |
|
||||||
41 | NCT03531268 | Withdrawn | Prospective Study to Evaluate the Clinical Utility of Perioperative Pharmacogenomic Testing |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT03531268 | 2018P000454 | October 20, 2018 | May 20, 2020 | May 20, 2020 | May 21, 2018 | January 17, 2019 |
|
|||
42 | NCT02044497 | Recruiting | Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
68 | All | up to 6 Years (Child) | NCT02044497 | IRB-P00006691 | May 2014 | July 2019 | December 2019 | January 24, 2014 | February 15, 2019 |
|
|||
43 | NCT03537547 | Recruiting | Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
120 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03537547 | 201609109 | May 4, 2018 | May 31, 2021 | May 31, 2021 | May 25, 2018 | July 20, 2018 |
|
|||
44 | NCT01135394 | Completed | Pharmacogenomics of Thiazolidinediones |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
134 | All | 35 Years to 64 Years (Adult) | NCT01135394 | HP-00043497 R01DK074828 |
PPAR | March 2009 | May 31, 2018 | May 31, 2018 | June 2, 2010 | September 27, 2018 |
|
||
45 | NCT02234427 | Completed Has Results |
Pharmacogenomics of Antiplatelet Response |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
34 | All | 45 Years to 75 Years (Adult, Older Adult) | NCT02234427 | PARes-III | PARes-III | June 2014 | April 2015 | May 2015 | September 9, 2014 | January 9, 2017 | January 9, 2017 |
|
|
46 | NCT03128463 | Recruiting | Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases |
|
|
Observational |
|
Other |
|
|
5000 | All | 18 Years and older (Adult, Older Adult) | NCT03128463 | 2016YFC0904800 | February 28, 2017 | December 31, 2018 | December 31, 2018 | April 25, 2017 | April 25, 2017 |
|
||||
47 | NCT01280825 | Recruiting | The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing |
|
Observational |
|
Other |
|
|
1200 | All | 18 Years and older (Adult, Older Adult) | NCT01280825 | 10-487-A | January 14, 2011 | November 2018 | December 2018 | January 21, 2011 | January 11, 2018 |
|
|||||
48 | NCT01855737 | Unknown † | The Study of Warfarin Maintenance Dose in Chinese Patients |
|
|
Observational |
|
Other |
|
|
1000 | All | 18 Years and older (Adult, Older Adult) | NCT01855737 | 2011-GZH1 | WADCH | June 2013 | December 2013 | January 2014 | May 16, 2013 | June 4, 2013 |
|
|||
49 | NCT03187184 | Recruiting | Implementing Preemptive Pharmacogenomic Testing for Colorectal Cancer Patients in a Community Oncology Clinic |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT03187184 | 021870 | CRCPGx | May 20, 2017 | December 20, 2018 | June 30, 2019 | June 14, 2017 | July 17, 2018 |
|
||
50 | NCT01886404 | Completed | EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients |
|
|
Observational |
|
Other |
|
|
30 | All | 50 Years and older (Adult, Older Adult) | NCT01886404 | 209-13-FB | EFV | December 2013 | May 2014 | August 2014 | June 25, 2013 | August 21, 2017 |
|
|||
51 | NCT02717039 | Recruiting | Pharmacogenomics of Heparin-Induced Thrombocytopenia |
|
|
Observational |
|
Other |
|
|
125 | All | 18 Years and older (Adult, Older Adult) | NCT02717039 | 1512277980 | PHIT | March 2016 | December 2022 | December 2022 | March 23, 2016 | January 25, 2019 |
|
|||
52 | NCT00890448 | Completed | Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate |
|
|
Observational |
|
Industry |
|
|
66 | All | Child, Adult, Older Adult | NCT00890448 | TAK-475_310 2008-006906-41 U1111-1112-3768 DOH-27-0410-2857 |
May 2009 | May 2010 | May 2010 | April 29, 2009 | May 24, 2012 |
|
||||
53 | NCT00384020 | Completed | Clinical Pharmacogenomics of Antidepressant Response |
|
|
Observational |
|
Other |
|
402 | All | 18 Years and older (Adult, Older Adult) | NCT00384020 | MD-095-PP-01 NSC 95-2314-B-400-001 |
January 2006 | January 2010 | January 2010 | October 4, 2006 | February 1, 2010 |
|
|||||
54 | NCT00817375 | Unknown † | Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
1000 | All | 19 Years to 89 Years (Adult, Older Adult) | NCT00817375 | 2003-01-12 | February 2003 | December 2018 | December 2018 | January 6, 2009 | December 31, 2015 |
|
|||
55 | NCT02748148 | Completed | Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT02748148 | MTM-309 | EMTM | April 2016 | September 2016 | September 2016 | April 22, 2016 | October 17, 2016 |
|
||
56 | NCT00584701 | Completed Has Results |
Pharmacogenomics in Autism Treatment |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other / Industry / NIH |
|
|
49 | All | 4 Years to 18 Years (Child, Adult) | NCT00584701 | 200715817-1 R21MH080026 |
PG | January 2008 | May 2009 | May 2009 | January 2, 2008 | July 24, 2012 | July 24, 2012 |
|
|
57 | NCT02972385 | Recruiting | Pharmacogenomics of Warfarin in Hispanics and Latinos |
|
|
Observational |
|
Other |
|
|
400 | All | 18 Years and older (Adult, Older Adult) | NCT02972385 | 1608762767 | September 2016 | September 2020 | September 2020 | November 23, 2016 | January 25, 2019 |
|
||||
58 | NCT03568266 | Not yet recruiting | Pharmacogenomics of Asparaginase Induced Hepatotoxicity |
|
|
Observational |
|
Other / NIH |
|
|
500 | All | 18 Years and older (Adult, Older Adult) | NCT03568266 | 9L-17-16 NCI-2018-00813 P30CA014089 |
February 25, 2019 | February 25, 2024 | February 25, 2025 | June 25, 2018 | December 19, 2018 |
|
||||
59 | NCT03818191 | Not yet recruiting New |
Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome |
|
|
Interventional |
Phase 4 |
|
Other / NIH |
|
|
800 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03818191 | 18-006428 1R01AA027486-01 1U01AA027487 |
April 1, 2019 | December 31, 2020 | December 31, 2020 | January 28, 2019 | January 31, 2019 |
|
|||
60 | NCT01815008 | Completed Has Results |
Pharmacogenomics of Antiplatelet Response - I |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
19 | All | 45 Years to 75 Years (Adult, Older Adult) | NCT01815008 | K23HL105897-PARes-I K23HL105897 |
PARes-I | October 2012 | June 2014 | June 2014 | March 20, 2013 | January 9, 2017 | January 9, 2017 |
|
|
61 | NCT01894555 | Completed Has Results |
Pharmacogenomics of Antiplatelet Response - II (PARes-II) |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
33 | All | 45 Years to 75 Years (Adult, Older Adult) | NCT01894555 | K23HL105897-PARes-II K23HL105897 |
PARes-II | January 2013 | August 2014 | August 2014 | July 10, 2013 | January 9, 2017 | January 9, 2017 |
|
|
62 | NCT03023891 | Recruiting | Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
|
50 | All | 18 Years to 45 Years (Adult) | NCT03023891 | 161942 5K23GM117395-03 |
February 15, 2017 | January 2019 | June 2019 | January 18, 2017 | August 10, 2018 |
|
|||
63 | NCT02715947 | Unknown † | Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
400 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02715947 | 2016 MTX/CSU/PS | December 2015 | December 2017 | December 2017 | March 22, 2016 | March 22, 2016 |
|
|||
64 | NCT03503292 | Recruiting | Pharmacogenomics and Post-Operative Nausea and Vomiting |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT03503292 | 17-011283 | May 2, 2018 | April 30, 2019 | October 2019 | April 19, 2018 | January 10, 2019 |
|
|||
65 | NCT01555021 | Terminated Has Results |
Pharmacogenomics for Antidepressant Guidance and Education |
|
|
Observational |
|
Other |
|
|
4 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01555021 | 2011-P-001921 | December 2011 | July 2012 | July 2012 | March 15, 2012 | November 5, 2018 | November 5, 2018 |
|
|||
66 | NCT02715960 | Unknown † | Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
500 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02715960 | 2016 AW/CSU/PS | December 2015 | December 2017 | December 2017 | March 22, 2016 | March 22, 2016 |
|
|||
67 | NCT00593905 | Unknown † | Pharmacogenomics in Pulmonary Arterial Hypertension |
|
|
Observational |
|
Other / NIH |
|
|
1300 | All | Child, Adult, Older Adult | NCT00593905 | RC-4590 RC #4590 |
July 2005 | July 2012 | July 2013 | January 15, 2008 | January 24, 2012 |
|
||||
68 | NCT00817011 | Unknown † | Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
1000 | All | 25 Years to 85 Years (Adult, Older Adult) | NCT00817011 | 2006-03-012 | PG | April 2006 | December 2016 | March 2018 | January 6, 2009 | December 31, 2015 |
|
||
69 | NCT00907452 | Unknown † | Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone |
|
|
Interventional |
Not Applicable |
|
Other |
|
1555 | All | 65 Years and older (Older Adult) | NCT00907452 | IFM 2007-03 Eudract: 2008-003486-58 |
April 2009 | September 2011 | May 22, 2009 | June 21, 2011 |
|
|||||
70 | NCT01453244 | Completed | Pharmacogenomic Research in Korean Patients With Hepatitis C |
|
Observational |
|
Other |
|
|
373 | All | 18 Years and older (Adult, Older Adult) | NCT01453244 | 11-037 | July 2011 | March 2013 | March 2013 | October 17, 2011 | June 3, 2013 |
|
|||||
71 | NCT03302364 | Recruiting | A Research in Pharmacogenomics and Accurate Medication of Risperidone |
|
|
Observational |
|
Other |
|
|
800 | All | Child, Adult, Older Adult | NCT03302364 | 2016[1240] | October 22, 2017 | November 2018 | December 2018 | October 5, 2017 | July 31, 2018 |
|
||||
72 | NCT01668706 | Completed | Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts |
|
Observational |
|
Other |
|
|
340 | All | 20 Years to 65 Years (Adult, Older Adult) | NCT01668706 | MD098SCW01 | March 2009 | December 2013 | December 2013 | August 20, 2012 | November 9, 2016 |
|
|||||
73 | NCT02479464 | Completed | Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical Setting |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
60 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02479464 | 09-002523 | HAMM | October 2009 | September 2010 | August 2014 | June 24, 2015 | July 3, 2015 | |||
74 | NCT03411759 | Completed | Cytochrome P450's Pharmacogenomics in Chronic Pain Patients |
|
Observational |
|
Other |
|
|
100 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT03411759 | FACIDOCRO | FACIDOCRO | January 8, 2018 | March 23, 2018 | March 23, 2018 | January 26, 2018 | March 29, 2018 |
|
||||
75 | NCT02573168 | Recruiting | Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Schizophrenia/Schizoaffective Disorder |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
531 | All | 18 Years and older (Adult, Older Adult) | NCT02573168 | EXCITE-013304-ARX1010.PTL | November 2015 | December 2019 | September 2020 | October 9, 2015 | February 12, 2018 |
|
|||
76 | NCT00415207 | Completed | Pharmacogenomics of Paclitaxel in Ovarian Cancer |
|
Observational |
|
Other |
|
300 | Female | 18 Years and older (Adult, Older Adult) | NCT00415207 | WRAMC WU# 04-23009 | December 2006 | August 2008 | December 2010 | December 22, 2006 | August 8, 2011 |
|
||||||
77 | NCT01118130 | Recruiting | Pharmacogenomics of Drug Safety in Multiple Sclerosis |
|
Observational |
|
Other |
|
|
300 | All | 18 Years and older (Adult, Older Adult) | NCT01118130 | H10-00494 | June 2010 | December 2018 | December 2018 | May 6, 2010 | November 6, 2017 |
|
|||||
78 | NCT01607021 | Unknown † | Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection |
|
Observational |
|
Other |
|
200 | All | 1 Year to 18 Years (Child, Adult) | NCT01607021 | beijing302-004 | April 2012 | December 2015 | December 2015 | May 28, 2012 | August 17, 2015 |
|
||||||
79 | NCT00516932 | Completed | Pharmacogenomics of Antidepressant Response in Children and Adolescents |
|
Observational |
|
Other / NIH |
|
|
211 | All | 7 Years to 17 Years (Child) | NCT00516932 | Pro00001300 P30MH066386-01 DSIR CTM 4398; Pro00001300 |
PARCA | May 2007 | October 2009 | October 2009 | August 16, 2007 | April 17, 2015 |
|
||||
80 | NCT02383290 | Completed | The Implementation of Pharmacogenomics Into Primary Care in British Columbia |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
190 | All | 18 Years and older (Adult, Older Adult) | NCT02383290 | H14-02979 | IPPC | April 2015 | October 2015 | December 2015 | March 9, 2015 | December 18, 2015 | |||
81 | NCT01437969 | Unknown † | Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment. |
|
|
Observational |
|
Other |
|
500 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01437969 | EPAT-IL28B | September 2011 | September 2012 | September 2012 | September 21, 2011 | April 17, 2012 |
|
|||||
82 | NCT00415181 | Completed | Pharmacogenomics of Paclitaxel in Ovarian Cancer |
|
Observational |
|
Other |
|
93 | Female | 18 Years and older (Adult, Older Adult) | NCT00415181 | AKF-319pro | September 2006 | January 2009 | March 2013 | December 22, 2006 | January 13, 2015 |
|
||||||
83 | NCT03674138 | Recruiting | Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
300 | All | 18 Years and older (Adult, Older Adult) | NCT03674138 | MCC-19578 | September 10, 2018 | December 10, 2020 | December 10, 2021 | September 17, 2018 | February 15, 2019 |
|
|||
84 | NCT00526084 | Unknown † | Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan |
|
Observational |
|
Other |
|
500 | All | 1 Year to 18 Years (Child, Adult) | NCT00526084 | 9561709144 | March 2007 | December 2009 | September 6, 2007 | September 6, 2007 |
|
|||||||
85 | NCT00269334 | Unknown † | Clinical Pharmacogenomics of Antidepressant Response |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
400 | All | 18 Years and older (Adult, Older Adult) | NCT00269334 | EC0931204 NSC 94-2314-B-400 -001 - |
December 2005 | November 2007 | December 23, 2005 | December 23, 2005 |
|
||||
86 | NCT00140036 | Completed | Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV). |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
137 | All | 18 Years and older (Adult, Older Adult) | NCT00140036 | CPTAIV-0020-366 A5961020 |
September 2002 | August 2005 | August 31, 2005 | March 3, 2008 |
|
||||
87 | NCT00414115 | Recruiting | National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children |
|
Observational |
|
Other / Industry |
|
|
7000 | All | Child, Adult, Older Adult | NCT00414115 | H04-70358 CW Health Centre of BC W04-0138 |
August 2005 | July 2019 | July 2019 | December 21, 2006 | November 6, 2017 |
|
|||||
88 | NCT00164073 | Unknown † | Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection |
|
|
Observational |
|
Other |
|
60 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00164073 | 122/03 | February 2004 | February 2007 | September 14, 2005 | August 1, 2007 |
|
||||||
89 | NCT02297126 | Completed | A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
4465 | All | 18 Years and older (Adult, Older Adult) | NCT02297126 | 1401206188 U01HG007762-01 |
INGenious | March 2015 | May 2018 | May 2018 | November 21, 2014 | July 16, 2018 |
|
||
90 | NCT02466477 | Active, not recruiting | Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder |
|
|
Interventional |
Phase 4 |
|
Industry / Other |
|
|
570 | All | 18 Years and older (Adult, Older Adult) | NCT02466477 | EXCITE-013304-ARX1009.PTL | June 2015 | September 2019 | October 2019 | June 9, 2015 | January 17, 2019 |
|
|||
91 | NCT00886535 | Unknown † | Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity |
|
Observational |
|
Other |
|
|
41 | Female | 18 Years and older (Adult, Older Adult) | NCT00886535 | PSHCI 08-047 | February 2010 | December 2013 | July 27, 2017 | April 23, 2009 | January 27, 2017 |
|
|||||
92 | NCT00131963 | Completed | A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel |
|
|
Observational |
|
Other / NIH |
|
|
94 | Female | 18 Years and older (Adult, Older Adult) | NCT00131963 | Pro00014267 DUMC-4522-04-1-R1 CDR0000438673 |
October 2003 | October 2014 | October 2014 | August 19, 2005 | July 25, 2016 |
|
||||
93 | NCT02096172 | Withdrawn | Urine Toxicology With Pharmacogenomic Interpretation Assay: UTOPIA |
|
Observational |
|
Industry / Other |
|
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT02096172 | 2013-002 | UTOPIA | March 2014 | July 2014 | March 26, 2014 | September 23, 2014 | ||||||
94 | NCT01071499 | Completed | Pharmacokinetics of Oral Morphine and Pharmacogenomics of CYP2D6 and UGT2B7, in an Urban Pediatric Population Presenting for Elective Surgery |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
43 | All | 2 Years to 6 Years (Child) | NCT01071499 | H09-03286 | March 2010 | November 2012 | November 2012 | February 19, 2010 | July 5, 2017 |
|
|||
95 | NCT03772535 | Enrolling by invitation | Pharmacogenetics for Pain Management in Joint Replacement Patients |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT03772535 | AORI 2018-0100 | PGx | December 3, 2018 | June 2019 | December 2019 | December 11, 2018 | December 11, 2018 |
|
||
96 | NCT01321372 | Completed | An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients |
|
Observational |
|
Other |
|
|
82 | All | Child, Adult, Older Adult | NCT01321372 | PMH-VOR | June 2007 | February 2011 | June 2011 | March 23, 2011 | March 19, 2013 |
|
|||||
97 | NCT02514369 | Unknown † | Pharmacogenomics of New Antiretrovirals |
|
Observational |
|
Other |
|
|
250 | All | 18 Years and older (Adult, Older Adult) | NCT02514369 | ARVLB01 | November 2012 | December 2015 | August 3, 2015 | August 3, 2015 |
|
||||||
98 | NCT02336269 | Recruiting | Evaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics |
|
Observational |
|
Industry |
|
|
100000 | All | 18 Years and older (Adult, Older Adult) | NCT02336269 | RDI-PGX-80801.01 | October 2013 | October 2017 | October 2019 | January 12, 2015 | January 12, 2015 |
|
|||||
99 | NCT02770339 | Completed | Pharmacogenomic Profiling of Pediatric Patients |
|
Observational |
|
Other |
|
|
100 | All | 3 Years to 18 Years (Child, Adult) | NCT02770339 | F160225002 | June 2016 | November 30, 2017 | November 30, 2017 | May 12, 2016 | February 20, 2018 |
|
|||||
100 | NCT01943383 | Completed | Pharmacogenomic Evaluation of Antihypertensive Responses in Induced Pluripotent Stem (iPS) Cells Study |
|
|
Observational |
|
Other |
|
|
21 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01943383 | IRB201600901 093-2013 |
PEAR-iPSC | August 2013 | May 2018 | May 2018 | September 17, 2013 | May 31, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.